RLFTY — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 44,107,000 | 5,324,000 | 8,176,000 |
| Dec 2025 | — | — | — | — | 51,530,000 | 9,473,000 | 13,189,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,384,000
Inventory
$896,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,196,000
EBITDA
$-10,215,000
Free Cash Flow
—
Enterprise Value
$66,522,360
Total Cash
$5,324,000
Total Debt
$24,000
Shares Out
169,993,750
Trailing EPS
$-0.30
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,000 | -10,515,000 | -9,906,000 | 51,530,000 | 13,189,000 | 38,341,000 | -7,208,000 |
| Dec 2024 | 0 | -2,000 | -1,000 | 93,000 | 7,000 | 86,000 | -3,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.20T | $1347.11 | — |
| JNJ | JOHNSON & JOHNSON | $651.11B | $270.47 | — |
| ABBV | AbbVie Inc. | $505.89B | $286.20 | — |
| MRK | Merck & Co., Inc. | $329.65B | $133.72 | — |
| NVS | NOVARTIS AG | $286.00B | $150.47 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics Announces CHF 4 Million Financing
2026-11-17 06:38 · Yahoo
MindMaze Therapeutics Reports New Home-Based Rehabilitation Results Ahead of MindMotion Lite Launch
2026-10-14 20:49 · Yahoo
OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand
2026-10-12 12:35 · Yahoo
MindMaze Therapeutics expands digital neurorehabilitation platform across US and Global markets
2026-10-07 15:44 · Yahoo
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
2026-10-05 12:35 · Yahoo
MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
2026-09-17 05:31 · Yahoo
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
2026-08-27 05:32 · Yahoo
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
2026-08-12 05:39 · Yahoo
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
2026-08-10 05:28 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.